Silo Pharma, Inc. — Director's Dealing 2014

Aug 1, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Point Capital, Inc. (PTCI)
CIK: 0001514183
Period of Report: 2013-06-20

Reporting Person: Weisblum Eric (Director, President and CCO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-06-20	Common Stock	A	3584160	—	Acquired	3584160	Direct

Footnotes

F1: The issuer price was $0.00001.